OpenVSafe by OpenVAERS
Search V-safe

Z67-33821-93043

2 vaccinations 2 coded responses 24 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
26-30
ZIP prefix
461 / IN
Registered
2021-04-01
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-01
    Registered in v-safe
  2. 2021-04-01
    Dose 1 — Pfizer-BioNTech
  3. 2021-04-01
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-04-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  5. 2021-04-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2021-04-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  7. 2021-04-05
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fever · Chills, Headache, Fatigue or tiredness, Nausea, Diarrhea
    Adult check-in
  8. 2021-04-06
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fatigue or tiredness, Nausea
    Adult check-in
  9. 2021-04-07
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  10. 2021-04-15
    Health check-in — day 14, dose 1
    Feeling: Fair
    Adult check-in
  11. 2021-04-21
    Dose 2 — Pfizer-BioNTech
  12. 2021-04-21
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Pain · Fatigue or tiredness, Nausea
    Adult check-in
  13. 2021-04-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  14. 2021-04-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Headache, Fatigue or tiredness, Nausea
    Adult check-in
  15. 2021-04-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache, Fatigue or tiredness
    Adult check-in
  16. 2021-04-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-04-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  18. 2021-04-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Muscle or body aches, Diarrhea · Be unable to do your normal daily activities
    Adult check-in
  19. 2021-04-28
    Health check-in — day 7, dose 2
    Feeling: Good · Headache
    Adult check-in
  20. 2021-05-06
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-05-12
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-05-19
    Survey response — day 28, dose 2
    MedDRA: Migraine — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities
    Free text: Migraines
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-05-26
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-06-02
    Health check-in — day 42, dose 2
    Feeling: Fair
    Adult check-in
  25. 2021-07-21
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-10-20
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2022-04-21
    Survey response — 12 months, dose 2
    MedDRA: Hypothyroidism, Tachycardia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit
    Free text: Hypothyroidism; tachycardia
    MedDRA releases: 2024-11 · check-in free text available
  28. 2022-04-21
    Report sent to call center — 12 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
  29. 2022-04-22

Vaccinations

DoseDateManufacturerCo-administered
12021-04-01Pfizer-BioNTech
22021-04-21Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2022-04-21 Unsuccessful

Free text

Release 8 — day 28, dose 2

2021-05-19

Symptoms: Migraines

Release 11 — 12 months, dose 2

2022-04-21

Symptoms: Hypothyroidism; tachycardia

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDHypothyroidism · · ✓
SDMigraine ✓ ✓ ✓
SDTachycardia · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release